┬░
Newark

Latest News - #University of Oxford

Italy has announced the appearance in the sale of the vaccine from COVID-19

The production of a European vaccine against the coronavirus will begin in September, said the head of the Italian biotech company Irbm Piero Di Lorenzo.

Work on the drug called ChAdOx1 are British and Italian specialists, in particular, the multinational pharmaceutical group AstraZeneca scientists at Oxford University and specialists of the Irbm working in the field of molecular biotechnology.

In Britain passed the first stage of the test, "Oxford vaccine" from COVID-19

The coronavirus vaccine, developed by scientists at Oxford University, has successfully passed the first phase of the test, announced on Monday the developers of the vaccine, published the results of testing in the British medical journal The Lancet.

In testing the vaccine, dubbed nCoV ChAdOx1-19, in the period from 23 April to 21 may was attended by 1077 people. Vaccination has led to the development of the subjects of the antibodies to COVID-19, said the authors.

Biography Of Gudny Johannesson

Icelandic statesman Gudny Johannesson (Gudni J├│hannesson) was born 26 Jun 1968 in Reykjavik. His father was a sports coach, the mother was engaged in teaching and journalism.

In 1987 he graduated from high school in Reykjavik.

The who declared the scientific breakthrough in the treatment COVID-19

The Director General of the world health organization tedros adhanom Ghebreyesus called "scientific breakthrough" results of clinical trials in the UK steroid dexamethasone for the treatment of COVID-19.

As revealed in the Oxford study, anti-inflammatory drug dexamethasone reduces the risk of death in patients with COVID-19, connected to the ventilator, 35% among patients receiving oxygen at 20%. The drug in Britain costs about five pounds (437 rubles - approx. ed.). The British government on Tuesday has approved dexamethasone for the treatment of COVID-19.

Italy and France signed a contract for 400 million doses of vaccine from COVID

The health Ministers of Italy, Germany, France and the Netherlands signed a contract with Anglo-Swedish pharmaceutical company Astrazeneca for the production of 400 million doses of vaccines against coronavirus, said the head of the Italian offices Roberto Speranza.

According to him, the vaccine will be "intended for the population of Europe."

The Oxford English dictionary will clarify the concept of "racism"

Publishers of the Oxford English dictionary (OED) are working on a more complete reflection of the concept of "racism" in their articles, told RIA Novosti the representative of Oxford University press Ella Percival.

According to her, the vocabulary expansion in this region takes place in the context of the global anti-racist protests caused by the death of the African-American George Floyd.

In the United States in the summer can begin the final stage of testing vaccines against COVID-19

The final stage of clinical trials of three vaccines against coronavirus in the United States may begin in the summer, reports the Wall Street Journal.

According to the Director of the Center for vaccine research at the National Institute of Allergy and infectious diseases John Maskaly, the third - final - stage trials will be held in dozens of US cities.

Scientists have rejected the efficacy of hydroxychloroquine in the coronavirus

Oxford scientists have found evidence that anti-malarial drug hydroxychloroquine may help in the treatment of people infected with coronavirus, said a research group.

Scientists from different countries explore the possibility of using this drug for the treatment of COVID-19. Researchers in the United States saw the drug prevention effect, and in Russia, hydroxychloroquine is considered by the Ministry of health as drugs for chemoprophylaxis COVID-19. The President of the United States Donald trump took this drug for the prevention of coronavirus after cases of coronavirus among the White house staff.